Please provide your email address to receive an email when new articles are posted on . In the PIVOTAL trial, patients undergoing hemodialysis with ferritin concentration less than 400 µg/L and a ...

Use of erythropoiesis-stimulating agents decreased, while use of iron increased. Meta-analysis reveals no statistically significant increase in the risks of infection, cardiovascular events, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The PIVOTAL Trial has shown in patients undergoing hemodialysis, that the use of higher-dose IV iron ...

Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the ...

A little over 3 years ago, researchers reported findings from PIVOTAL, the largest prospective, randomized trial to assess an aggressive versus conservative iron-repletion strategy in patients with ...

Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis. High-dose intravenous (IV) iron reduces the risk for acute myocardial infarction in patients receiving ...

Iron deficiency anemia common but underdiagnosed and undertreated in patients with gastrointestinal conditions; high-dose intravenous iron an effective treatment option CHICAGO--(BUSINESS ...

A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis.